Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.63
-0.22 (-3.76%)
Aug 14, 2025, 12:05 PM - Market open
Silence Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 41.74 | 121.33 | 68.79 | 66.05 | 99.57 | 37.48 | Upgrade
|
| Short-Term Investments | 72.42 | 26 | - | 19.67 | - | 13.65 | Upgrade
|
| Cash & Short-Term Investments | 114.16 | 147.33 | 68.79 | 85.72 | 99.57 | 51.13 | Upgrade
|
| Cash Growth | -39.62% | 114.18% | -19.75% | -13.91% | 94.75% | 15.18% | Upgrade
|
| Accounts Receivable | 0.09 | 0.97 | 0.29 | 1.1 | 0.45 | 40.01 | Upgrade
|
| Other Receivables | 19.96 | 25.94 | 23.69 | 19.79 | 11.04 | 5.75 | Upgrade
|
| Receivables | 20.04 | 26.91 | 23.98 | 20.9 | 11.49 | 45.76 | Upgrade
|
| Prepaid Expenses | - | 13.12 | 10.39 | 9.88 | 5.83 | 5.38 | Upgrade
|
| Other Current Assets | 14.36 | - | - | - | - | 2.04 | Upgrade
|
| Total Current Assets | 148.55 | 187.37 | 103.15 | 116.5 | 116.9 | 104.31 | Upgrade
|
| Property, Plant & Equipment | 1.83 | 1.98 | 2.31 | 2.65 | 2.63 | 1.54 | Upgrade
|
| Long-Term Investments | - | - | - | 0.34 | 0.41 | 0.41 | Upgrade
|
| Goodwill | 10.62 | 9.39 | 9.98 | 9.65 | 10.28 | 11.09 | Upgrade
|
| Other Intangible Assets | 0.32 | 0.31 | 0.36 | 0.39 | 0.03 | 0.02 | Upgrade
|
| Other Long-Term Assets | 3.91 | 3.59 | 3.65 | - | - | - | Upgrade
|
| Total Assets | 165.23 | 202.64 | 119.45 | 129.53 | 130.25 | 117.38 | Upgrade
|
| Accounts Payable | 14.31 | 3.7 | 3.35 | 3.84 | 5.5 | 3.12 | Upgrade
|
| Accrued Expenses | - | 12.05 | 11.72 | 10.67 | 8.85 | 8.06 | Upgrade
|
| Current Portion of Leases | - | 0.12 | 0.23 | 0.54 | 0.19 | 0.47 | Upgrade
|
| Current Income Taxes Payable | - | 0.65 | 0.47 | 0.71 | 0.25 | - | Upgrade
|
| Current Unearned Revenue | 0.46 | 0.31 | 6.57 | 10.68 | 5.75 | 23.27 | Upgrade
|
| Total Current Liabilities | 14.77 | 16.82 | 22.34 | 26.44 | 20.54 | 34.92 | Upgrade
|
| Long-Term Leases | - | - | 0.12 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 56.31 | 51.79 | 75 | 76.49 | 98.17 | 70.09 | Upgrade
|
| Total Liabilities | 71.08 | 68.61 | 97.46 | 102.93 | 118.71 | 105.01 | Upgrade
|
| Common Stock | 10.29 | 10.29 | 8.85 | 6.49 | 6.08 | 5.69 | Upgrade
|
| Additional Paid-In Capital | 615.11 | 609.56 | 455.77 | 273.11 | 249.6 | 209.89 | Upgrade
|
| Retained Earnings | -531.25 | -485.83 | -442.62 | -317.2 | -301.91 | -251.51 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 64.19 | 57.78 | 48.3 | Upgrade
|
| Shareholders' Equity | 94.16 | 134.02 | 21.99 | 26.59 | 11.54 | 12.37 | Upgrade
|
| Total Liabilities & Equity | 165.23 | 202.64 | 119.45 | 129.53 | 130.25 | 117.38 | Upgrade
|
| Total Debt | - | 0.12 | 0.35 | 0.54 | 0.19 | 0.47 | Upgrade
|
| Net Cash (Debt) | 114.16 | 147.22 | 68.44 | 85.18 | 99.39 | 50.66 | Upgrade
|
| Net Cash Growth | -39.54% | 115.09% | -19.65% | -14.29% | 96.17% | 15.12% | Upgrade
|
| Net Cash Per Share | 2.42 | 3.18 | 1.85 | 2.65 | 3.35 | 1.86 | Upgrade
|
| Filing Date Shares Outstanding | 47.23 | 47.22 | 46.5 | 35.95 | 29.93 | 27.77 | Upgrade
|
| Total Common Shares Outstanding | 47.23 | 47.22 | 39.62 | 35.94 | 29.93 | 27.77 | Upgrade
|
| Working Capital | 133.79 | 170.54 | 80.82 | 90.06 | 96.36 | 69.39 | Upgrade
|
| Book Value Per Share | 1.99 | 2.84 | 0.56 | 0.74 | 0.39 | 0.45 | Upgrade
|
| Tangible Book Value | 83.22 | 124.32 | 11.65 | 16.56 | 1.23 | 1.25 | Upgrade
|
| Tangible Book Value Per Share | 1.76 | 2.63 | 0.29 | 0.46 | 0.04 | 0.05 | Upgrade
|
| Machinery | - | 6.34 | 6.44 | 6.01 | 6.92 | 5.55 | Upgrade
|
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.